SYNTHESIS AND EVALUATION OF NEW ANTILEISHMANIAL AGENTS

CHF 95.55
Auf Lager
SKU
7PJFP8EFHOK
Stock 1 Verfügbar
Free Shipping Kostenloser Versand
Geliefert zwischen Do., 06.11.2025 und Fr., 07.11.2025

Details

In this work, we decided to synthesize an expanded series of Sterioselective indole oxime ethers and Biaryl bifunctional ethers of prototype-I-II and investigated their biological effects against the Leishmania parasites. The newly synthesized compounds exhibited interesting biological activity. This work involves design and synthesis of novel azoles with aryloxy and oximino functions making use of our developed methodology of the water mediated Mannichaldol-type adducts. The preliminary investigations of biological results revealed that, these compounds have potential as antileishmanial agents and has opened a new avenue for further exploration.

Autorentext

Dr. Santosh M. Surwase is a Professor at Department of Chemistry at Shri Chhatrapati Shivaji College, Omerga, Dist. Osmanabad, M.S., India. He did M.Sc. and Ph.D. from S.R.T.M. University, Nanded, M.S., India. He has 17 years of teaching experience to both UG and PG students.

Cart 30 Tage Rückgaberecht
Cart Garantie

Weitere Informationen

  • Allgemeine Informationen
    • GTIN 09786204748078
    • Genre Chemistry
    • Anzahl Seiten 160
    • Herausgeber LAP LAMBERT Academic Publishing
    • Größe H220mm x B150mm x T10mm
    • Jahr 2022
    • EAN 9786204748078
    • Format Kartonierter Einband
    • ISBN 6204748076
    • Veröffentlichung 19.08.2022
    • Titel SYNTHESIS AND EVALUATION OF NEW ANTILEISHMANIAL AGENTS
    • Autor Santosh Surwase , Yogesh Mane , Bhimrao Khade
    • Untertitel Design, Synthesis and Evaluation of New Antileishmanial Agents
    • Gewicht 256g
    • Sprache Englisch

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470